ÆíÆò¼¼Æ÷¾ÏÁ¾ÀÌ µ¿¹ÝµÈ ºñ°ÀÇ µµ¸³À¯µÎÁ¾ - 2¿¹ º¸°í -
Nasal Inverted Papilloma Associated With Squamous Cell Carcinoma - A Report of Two Cases -
±¸¹ÌÁø, ±èµ¿¼®, ¹è¿µ°æ, ±è¿ë´ë,
¼Ò¼Ó »ó¼¼Á¤º¸
±¸¹ÌÁø ( Gu Mi-Jin )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èµ¿¼® ( Kim Dong-Sug )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹è¿µ°æ ( Bae Young-Kyung )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è¿ë´ë ( Kim Yong-Dae )
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°úÇб³½Ç
KMID : 0357920010350030248
Abstract
Nasal inverted papilloma (IP) is a benign neoplasm that may be associated with squamous cell carcinoma (SCC). Several studies have suggested that human papilloma virus 16/18 (HPV 16/18) and p53 are closely related to the pathogenesis of IP with transformation to squamous cell carcinoma (IP-SCC). This study was conducted to investigate the role of HPV 16/18 and p53 in the pathogenesis of IP-SCC using immunohistochemistry. We studied two cases of IP-SCC and 10 cases of IP. None of the IP cases presented positivity for HPV 16/18 or p53 protein. Two cases of IP-SCC showed negative reactions for HPV 16/18. The SCC portion of the IP-SCC showed strong positivity for p53, while the IP portion of the IP-SCC was negative for p53. MIB-1 labeling index (LI) was estimated in the IP cases and the IP-SCC as well. In terms of MIB-1 LI, there was no statistical significance between IP and IP-SCC, and between the IP portion and the SCC portion in the cases of IP-SCC. In conclusion, we believe that alteration of the p53 protein is related to IP with malignant transformation, but further studies are required to investigate the correlation of HPV 16/18 and p53 in the pathogenesis of IP with malignant transformation, and the significance of the MIB-1 LI and p53 as biomarkers in IP.
Å°¿öµå
Inverted papilloma;Squamous cell carcinoma;Human papillomavirus 16/18; 53
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸